Filing Details
- Accession Number:
- 0001415889-24-023809
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-20 19:26:16
- Reporting Period:
- 2024-09-19
- Accepted Time:
- 2024-09-20 19:26:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1472012 | Immunome Inc. | IMNM | Pharmaceutical Preparations (2834) | 770694340 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1994071 | Max Rosett | C/O Immunome, Inc. 18702 N. Creek Parkway, Suite 100 Bothell WA 98011 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-19 | 42,000 | $1.05 | 61,856 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-19 | 14,380 | $16.01 | 47,476 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2024-09-19 | 42,000 | $0.00 | 42,000 | $1.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 91,848 | 2033-03-22 | No | 4 | M | Direct |
Footnotes
- The shares were sold pursuant to sell to cover transactions.
- The weighted average sale price for the transaction report was $16.01, and the range of prices were between $15.97 and $16.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- The Reporting Person's Form 3 filed on October 12, 2023 contains a scrivener's error reflecting an exercise price of $1.06 instead of the correct exercise price of $1.05.
- 25% of the shares vested on March 24, 2023, and the remaining shares shall vest in 36 monthly installments thereafter.
Billionaire Hedge Funds
